Gregory Sullivan
Board Member
Carvana Co. (CVNA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2017-01-01–present
-
Tonix Pharmaceuticals Holding Corp. (TNXP)
Proxy statement
Start not stated–2026-08-20
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Medical Officer | $519,168 | $1,216,542 |
| 2024 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Medical Officer | $499,200 | $922,444 |
| 2023 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Medical Officer | $480,000 | $951,998 |
| 2022 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Medical Officer | $461,120 | $1,478,661 |
| 2021 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Medical Officer | $440,000 | $2,247,785 |
| 2020 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Medical Officer | $420,000 | $1,382,420 |
| 2019 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Medical Officer | $400,000 | $652,393 |
| 2018 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Medical Officer | $335,000 | $721,855 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.